A
Acura Pharmaceuticals Inc
OTC:ACUR
Acura Pharmaceuticals Inc
OTC:ACUR
Price:
0.0005
USD
Market Cap:
$33.2k
Balance Sheet
Balance Sheet Decomposition
Acura Pharmaceuticals Inc
Acura Pharmaceuticals Inc
Balance Sheet Decomposition is not available for
Acura Pharmaceuticals Inc
Acura Pharmaceuticals Inc
Balance Sheet
Acura Pharmaceuticals Inc
Acura Pharmaceuticals Inc
Currency: USD
| Dec-1998 | Dec-1999 | Dec-2000 | Dec-2001 | Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
2
|
1
|
1
|
0
|
9
|
1
|
3
|
0
|
0
|
31
|
30
|
30
|
24
|
36
|
7
|
12
|
1
|
0
|
3
|
2
|
0
|
1
|
0
|
0
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Cash Equivalents |
2
|
1
|
1
|
0
|
9
|
1
|
3
|
0
|
0
|
31
|
30
|
30
|
24
|
36
|
7
|
12
|
1
|
0
|
3
|
2
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
0
|
0
|
0
|
20
|
14
|
0
|
11
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
1
|
3
|
4
|
0
|
1
|
0
|
0
|
0
|
0
|
3
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Accounts Receivables |
1
|
3
|
4
|
0
|
1
|
0
|
0
|
0
|
0
|
3
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
6
|
4
|
3
|
3
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
10
|
3
|
0
|
0
|
0
|
0
|
1
|
0
|
3
|
3
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
10
|
7
|
8
|
4
|
13
|
2
|
3
|
0
|
0
|
45
|
42
|
31
|
24
|
36
|
28
|
27
|
13
|
14
|
6
|
3
|
0
|
1
|
1
|
0
|
|
| PP&E Net |
5
|
3
|
5
|
6
|
5
|
3
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
|
| PP&E Gross |
5
|
3
|
5
|
6
|
5
|
3
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
14
|
11
|
10
|
9
|
8
|
9
|
4
|
3
|
3
|
2
|
1
|
1
|
1
|
1
|
2
|
2
|
0
|
2
|
2
|
2
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
1
|
1
|
1
|
1
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
1
|
2
|
2
|
1
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
16
N/A
|
13
-21%
|
15
+22%
|
11
-27%
|
19
+75%
|
7
-66%
|
5
-25%
|
2
-64%
|
2
-9%
|
46
+2 717%
|
43
-6%
|
32
-26%
|
25
-20%
|
37
+46%
|
29
-22%
|
29
-1%
|
16
-44%
|
17
+6%
|
8
-52%
|
5
-44%
|
2
-53%
|
3
+19%
|
2
-32%
|
1
-50%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
2
|
2
|
3
|
3
|
3
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Accrued Liabilities |
4
|
6
|
6
|
6
|
3
|
4
|
1
|
0
|
0
|
0
|
1
|
0
|
1
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
0
|
|
| Short-Term Debt |
10
|
4
|
2
|
3
|
0
|
0
|
0
|
3
|
29
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
3
|
0
|
0
|
6
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
22
|
5
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
16
|
12
|
11
|
12
|
7
|
6
|
1
|
3
|
29
|
22
|
6
|
2
|
1
|
1
|
1
|
1
|
3
|
3
|
3
|
5
|
1
|
1
|
8
|
1
|
|
| Long-Term Debt |
26
|
41
|
57
|
64
|
25
|
53
|
5
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
10
|
8
|
5
|
3
|
0
|
4
|
6
|
0
|
0
|
|
| Other Liabilities |
2
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
11
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
45
N/A
|
55
+22%
|
69
+25%
|
77
+12%
|
32
-59%
|
59
+86%
|
6
-90%
|
8
+31%
|
40
+402%
|
27
-33%
|
6
-78%
|
2
-66%
|
1
-43%
|
1
-54%
|
1
+168%
|
11
+654%
|
11
+3%
|
9
-17%
|
7
-22%
|
5
-34%
|
6
+25%
|
7
+27%
|
8
+4%
|
1
-91%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
3
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Retained Earnings |
57
|
77
|
89
|
102
|
161
|
210
|
280
|
292
|
318
|
322
|
307
|
323
|
336
|
326
|
335
|
349
|
362
|
367
|
375
|
380
|
384
|
388
|
389
|
390
|
|
| Additional Paid In Capital |
29
|
36
|
35
|
36
|
149
|
157
|
276
|
288
|
276
|
340
|
344
|
353
|
360
|
362
|
362
|
367
|
367
|
375
|
376
|
380
|
380
|
383
|
383
|
390
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Treasury Stock |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
29
N/A
|
42
-46%
|
53
-26%
|
65
-23%
|
12
+81%
|
52
-324%
|
1
+98%
|
6
-465%
|
38
-521%
|
19
N/A
|
37
+98%
|
30
-19%
|
24
-19%
|
37
+51%
|
28
-25%
|
18
-35%
|
5
-72%
|
8
+56%
|
1
-85%
|
0
N/A
|
4
-13 296%
|
5
-31%
|
6
-24%
|
0
N/A
|
|
| Total Liabilities & Equity |
16
N/A
|
13
-21%
|
15
+22%
|
11
-27%
|
19
+75%
|
7
-66%
|
5
-25%
|
2
-64%
|
2
-9%
|
46
+2 717%
|
43
-6%
|
32
-26%
|
25
-20%
|
37
+46%
|
29
-22%
|
29
-1%
|
16
-44%
|
17
+6%
|
8
-52%
|
5
-44%
|
2
-53%
|
3
+19%
|
2
-32%
|
1
-50%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
7
|
9
|
9
|
9
|
9
|
9
|
9
|
10
|
10
|
12
|
12
|
21
|
21
|
21
|
22
|
65
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
218
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
